Skip to content
Cohance Lifesciences
Home
About
Our Company
Vision and Values
Board of Directors
Management Committee
Corporate Information
Business Units
CDMO
API and Formulations
Clinical research & Bio Analytical Studies
Research and Development
Infrastructure
Overview
Manufacturing Units
API Unit I – Jaggayapet
API Unit II – Atchutapuram
API Unit III – Ankaleshwar
API Unit IV – Nacharam
API Unit V – Parwada, Vizag
FDF/PFI Unit I – Nacharam
FDF/PFI Unit II – Jadcherla
R&D
API R&D Unit I – Patancheru
API R&D Unit II – Ankaleshwar
API R&D Unit III – Nacharam
FDF R&D Unit I – Nacharam
Clinical Research and Bio Analytical Studies
CRBio – Balanagar
Sustainability
EHS
CSR
Governance
Life at Cohance
We are Cohancers
Cohance with Us
Gallery
Investors
Media
Press release/announcement
Media coverage
Contact
Home
About
Our Company
Vision and Values
Board of Directors
Management Committee
Corporate Information
Business Units
CDMO
API and Formulations
Clinical research & Bio Analytical Studies
Research and Development
Infrastructure
Overview
Manufacturing Units
API Unit I – Jaggayapet
API Unit II – Atchutapuram
API Unit III – Ankaleshwar
API Unit IV – Nacharam
API Unit V – Parwada, Vizag
FDF/PFI Unit I – Nacharam
FDF/PFI Unit II – Jadcherla
R&D
API R&D Unit I – Patancheru
API R&D Unit II – Ankaleshwar
API R&D Unit III – Nacharam
FDF R&D Unit I – Nacharam
Clinical Research and Bio Analytical Studies
CRBio – Balanagar
Sustainability
EHS
CSR
Governance
Life at Cohance
We are Cohancers
Cohance with Us
Gallery
Investors
Media
Press release/announcement
Media coverage
Contact
Investors
You are here:
Home
Investors
Investors Presentation
Q1 FY 25
FY 24
Q3 FY 24
H1 FY24
June 2023
March 2023
December 2022
Corporate Governance
Newspaper Advertisement
Notice of AGM for FY 2022-23
Notices sent to Statutory Authorities
Scheme - Merger of ZCL and Avra with Cohance
Go to Top